The evaluation of dyslipidemia benefit effect of thiazolidinediones with statins in patients with type 2 diabetes mellitus
- At: 2010 FIP Congress in Lisbon (Portugal)
- Type: Poster
- By: HUANG, Houjen (Mackay Memorial Hospital Taitung Branch, Taitung, China Taiwan)
- Co-author(s): Hsiao, Ya Chun (Mackay Memorial Hospital Taitung Branch, TAITUNG, China Taiwan)
Tsai, Tong Rong (KAOHSIUNG MEDICAL UNIVERSITY College of Pharmacy, KAOHSIUNG, China Taiwan)
Background and Objectives: Statins are often prescribed for Type 2 diabetes to reduce LDL-C in the clinical practice setting. Oral hypoglycemic agents (OHA) Thiazolidinediones (TZDs), known to enhance insulin sensitivity in skeletal and adipose tissue, can lower blood glucose and improve blood triglyceride and cholesterol level. The objective of.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.